Starting today, people with Parkinson's disease will have a new treatment option, thanks to U.S. Food and Drug Administration approval of groundbreaking new technology.
An industry source said “most, if not all” of the people at CDRH who were recently dismissed are now being asked to return.
The FDA approved adaptive deep brain stimulation (DBS) technology (BrainSense adaptive DBS and BrainSense electrode ...
A number of agencies are looking to rehire federal workers who lost their jobs as part of the Trump administration's mission ...
The Trump administration is reinstating some employees in the Food and Drug Administration's medical devices division after ...
The reversal is the latest example of President Donald Trump and billionaire Elon Musk's chaotic approach to cost-cutting, ...
Early in the new year, the US Food and Drug Administration (FDA) released two anticipated draft guidance documents focused on artificial ...
The agency changed course just days after firing employees who oversee the safety of food and life-sustaining medical devices ...